Aprogen Biologics Statistics

Total Valuation

KRX:003060 has a market cap or net worth of KRW 49.59 billion. The enterprise value is 296.56 billion.

Market Cap	49.59B
Enterprise Value	296.56B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

KRX:003060 has 13.17 million shares outstanding. The number of shares has increased by 57.17% in one year.

Current Share Class	13.17M
Shares Outstanding	13.17M
Shares Change (YoY)	+57.17%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	0.08%
Float	5.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.68
PB Ratio	0.18
P/TBV Ratio	0.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.74
EV / Sales	4.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.20

Financial Position

The company has a current ratio of 0.67, with a Debt / Equity ratio of 0.82.

Current Ratio	0.67
Quick Ratio	0.32
Debt / Equity	0.82
Debt / EBITDA	n/a
Debt / FCF	-4.78
Interest Coverage	-11.49

Financial Efficiency

Return on equity (ROE) is -51.29% and return on invested capital (ROIC) is -26.88%.

Return on Equity (ROE)	-51.29%
Return on Assets (ROA)	-13.04%
Return on Invested Capital (ROIC)	-26.88%
Return on Capital Employed (ROCE)	-34.34%
Weighted Average Cost of Capital (WACC)	3.71%
Revenue Per Employee	187.28M
Profits Per Employee	-435.63M
Employee Count	391
Asset Turnover	0.12
Inventory Turnover	1.94

Taxes

Income Tax	-1.08B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -97.59% in the last 52 weeks. The beta is -0.09, so KRX:003060's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	-97.59%
50-Day Moving Average	5,147.32
200-Day Moving Average	8,003.16
Relative Strength Index (RSI)	14.94
Average Volume (20 Days)	599,527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:003060 had revenue of KRW 73.23 billion and -170.33 billion in losses. Loss per share was -12,930.00.

Revenue	73.23B
Gross Profit	-27.35B
Operating Income	-122.89B
Pretax Income	-169.38B
Net Income	-170.33B
EBITDA	-103.70B
EBIT	-122.89B
Loss Per Share	-12,930.00

Full Income Statement

Balance Sheet

The company has 51.63 billion in cash and 228.80 billion in debt, giving a net cash position of -177.16 billion or -13,450.44 per share.

Cash & Cash Equivalents	51.63B
Total Debt	228.80B
Net Cash	-177.16B
Net Cash Per Share	-13,450.44
Equity (Book Value)	277.57B
Book Value Per Share	15,764.78
Working Capital	-74.60B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -38.23 billion and capital expenditures -9.62 billion, giving a free cash flow of -47.86 billion.

Operating Cash Flow	-38.23B
Capital Expenditures	-9.62B
Depreciation & Amortization	19.18B
Net Borrowing	135.14B
Free Cash Flow	-47.86B
FCF Per Share	-3,633.40

Full Cash Flow Statement

Margins

Gross margin is -37.36%, with operating and profit margins of -167.82% and -232.61%.

Gross Margin	-37.36%
Operating Margin	-167.82%
Pretax Margin	-231.31%
Profit Margin	-232.61%
EBITDA Margin	-141.62%
EBIT Margin	-167.82%
FCF Margin	n/a

Dividends & Yields

KRX:003060 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.17%
Shareholder Yield	-57.17%
Earnings Yield	-343.47%
FCF Yield	-96.50%

Stock Splits

The last stock split was on March 27, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Mar 27, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

KRX:003060 has an Altman Z-Score of -1.44 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.44
Piotroski F-Score	2